GRIK2 and myalgic encephalomeyelitis/chronic fatigue syndrome: GRIK2 was proposed as a candidate biomarker in Chronic Fatigue Syndrome (CFS) after it was detected in the peripheral blood of CFS patients as differentially expressed [58].